As both ERK1/2 and SPHK1 have been implicated in several oncogenic pathways, the inhibition of SPHK1 by SKI-5C may effectively down-regulate multiple molecular pathways in breast cancer by its potential to interrupt this positive feedback loop. This evidence concerns the gene SPHK1 and breast cancer.